Guy Cantin - Concepedia

Author

Guy Cantin

Hôpital du Saint-Sacrement

Also Known As

G CANTIN, G Cantin, G. Cantin, Guy Cantin

Publications

539

Citations

H-Index

Concepts

All Affiliations

Hôpital du Saint-Sacrement Ontario Institute for Cancer Research CancerCare Manitoba Hôpital de l'Enfant-Jésus McGill University

About

Guy Cantin is an author at Hôpital du Saint-Sacrement specializing in medicine, hematology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	198
2	Blood Transplantation	2	2	107
3	Immunology	2	2	117
4	Health Sciences	1	1	50
5	Public Health	1	1	41

Guy Cantin

Publications

504

Citations

H-Index

Page 1

	Year	Citations
A randomized phase 3 trial of thalidomide and prednisone as maintenance therapy after ASCT in patients with MM with a quality-of-life assessment: the National Cancer Institute of Canada Clinicals Trials Group Myeloma 10 Trial A. Keith Stewart, Suzanne Trudel, Nizar J. Bahlis, Blood	2013	144
A prospective study of G-CSF effects on hemostasis in allogeneic blood stem cell donors Renée LeBlanc, Jean Roy, C. Demers, Bone Marrow Transplantation TransplantationMarrow TransplantationG-csf EffectsStem Cell MobilizationImmunology	1999	76
Treatment of essential thrombocythemia during pregnancy with interferon-alpha. Robert Delage, C. Demers, Guy Cantin, PubMed	1996	57
ABVD (8 cycles) versus BEACOPP (4 escalated cycles => 4 baseline) in stage III-IV high-risk Hodgkin lymphoma (HL): First results of EORTC 20012 Intergroup randomized phase III clinical trial. Patrice Carde, Matthias Karrasch, Catherine Fortpied, Journal of Clinical Oncology Beacopp PtsPrimary EndpointCancer ManagementClinical EndpointPathology	2012	50
Anti‐PP<sub>1</sub>P<sup>k</sup> and early abortion Guy Cantin, J. Lyonnais Transfusion FertilityP PhenotypeP Phenotype MothersPhenotype P. RecurrentImmunology	1983	41
Canadian multicenter pilot trial of haploidentical donor transplantation Irwin Walker, Nadine Shehata, Guy Cantin, Blood Cells Molecules and Diseases TransplantationHematologyHaploidentical Donor TransplantationGraft SurvivalSurgery	2004	31
Bortezomib Added to R-CVP Is Safe and Effective for Previously Untreated Advanced-Stage Follicular Lymphoma: A Phase II Study by the National Cancer Institute of Canada Clinical Trials Group Laurie H. Sehn, David MacDonald, S. Rubin, Journal of Clinical Oncology	2011	30
Blood-derived stem cell collection in acute nonlymphoblastic leukemia: predictive factors for a good yield. Guy Cantin, D Marchand-Laroche, M Bouchard, PubMed	1989	28
High‐dose cytosine arabinoside for acute nonlymphocytic leukemia Guy Cantin, James K. Brennan American Journal of Hematology	1984	22
Comparison of Serious Adverse Events Between the Original and a Generic Docetaxel in Breast Cancer Patients Éric Poirier, Christine Desbiens, Brigitte Poirier, Annals of Pharmacotherapy	2013	14

Page 1